Treatment of Cryptococcal Meningitis in KwaZulu-Natal, South Africa

High HIV incidence in a community with high HIV prevalence in rural South Africa: findings from a prospective population-based study

(2009) Till Bärnighausen et al.   AIDS

Estimation of the current global burden of cryptococcal meningitis among persons living with HIV/AIDS

(2009) Benjamin J Park et al.   AIDS

Adult mortality and antiretroviral treatment roll-out in rural KwaZulu-Natal, South Africa

(2009) Abraham J Herbst et al.   BULLETIN OF THE WORLD HEALTH ORGANIZATION

Independent Association between Rate of Clearance of Infection and Clinical Outcome of HIV‐Associated Cryptococcal Meningitis: Analysis of a Combined Cohort of 262 Patients

(2009) Tihana Bicanic et al.   CLINICAL INFECTIOUS DISEASES

Early Antiretroviral Therapy Reduces AIDS Progression/Death in Individuals with Acute Opportunistic Infections: A Multicenter Randomized Strategy Trial

(2009) Andrew R. Zolopa et al.   PLoS One

Outcomes of Cryptococcal Meningitis in Uganda Before and After the Availability of Highly Active Antiretroviral Therapy

(2008) Andrew Kambugu et al.   CLINICAL INFECTIOUS DISEASES

Dose Response Effect of High‐Dose Fluconazole for HIV‐Associated Cryptococcal Meningitis in Southwestern Uganda

(2008) Nicky Longley et al.   CLINICAL INFECTIOUS DISEASES

AIDS-associated cryptococcosis: a comparison of epidemiology, clinical features and outcome in the pre- and post-HAART eras. Experience of a single centre in Italy

(2008) S Antinori et al.   HIV MEDICINE

The Use of HAART Is Associated With Decreased Risk of Death During Initial Treatment of Cryptococcal Meningitis in Adults in Botswana

(2008) Gregory P Bisson et al.   JAIDS-JOURNAL OF ACQUIRED IMMUNE DEFICIENCY SYNDROMES